Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVAGRAF for prophylaxis against renal transplant rejection
2011-003184-29Phase 4Active
- Sponsor
- CHRU Tours
- Start
- Sep 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney allograft rejection, sponsored by CHRU Tours. Started Sep 2011; status: active.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2011-003184-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003184-29.